• Insulet's Q3 2026 GAAP diluted EPS rose 64% year-over-year to $2.03.
• Revenue climbed 19% year-over-year to $842 million.
• The board authorized a $1 billion share repurchase program, with $400 million expected to be allocated toward repurchases in Q4.
• FY26 guidance projects GAAP revenue growth of 22%-23%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.